These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 21716050

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection.
    Harris TG, Miller L, Kulasingam SL, Feng Q, Kiviat NB, Schwartz SM, Koutsky LA.
    Am J Obstet Gynecol; 2009 May; 200(5):489.e1-8. PubMed ID: 19375566
    [Abstract] [Full Text] [Related]

  • 3. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM.
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [Abstract] [Full Text] [Related]

  • 4. Cervical cancer risk and use of depot-medroxyprogesterone acetate in Costa Rica.
    Oberle MW, Rosero-Bixby L, Irwin KL, Fortney JA, Lee NC, Whatley AS, Bonhomme MG.
    Int J Epidemiol; 1988 Dec; 17(4):718-23. PubMed ID: 2976059
    [Abstract] [Full Text] [Related]

  • 5. Depo medroxyprogesterone acetate (DMPA) and combined oral contraceptives and cervical carcinoma in-situ in women aged 50 years and under.
    Hoyo C, Cousins DS, Bisgrove EZ, Gaines MM, Schwingl PJ, Fortney JA.
    West Indian Med J; 2004 Dec; 53(6):406-12. PubMed ID: 15816269
    [Abstract] [Full Text] [Related]

  • 6. Cytologic and histologic review of atypical glandular cells (AGC) detected during cervical cytology screening.
    Jeng CJ, Liang HS, Wang TY, Shen J, Yang YC, Tzeng CR.
    Int J Gynecol Cancer; 2003 Dec; 13(4):518-21. PubMed ID: 12911731
    [Abstract] [Full Text] [Related]

  • 7. Depot medroxyprogesterone acetate: a risk factor for cervical stenosis after loop electrosurgical excisional procedure management of cervical intraepithelial neoplasia?
    Martirosian TE, Smith SC, Baras AS, Darracott MM.
    J Low Genit Tract Dis; 2010 Jan; 14(1):37-42. PubMed ID: 20040834
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Contraception; 1992 Apr; 45(4):299-312. PubMed ID: 1387601
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M, Koetsawang S, Patrasupapong N, Dinchuen P, d'Arcangues C, Piaggio G, Pinol A.
    Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
    [Abstract] [Full Text] [Related]

  • 18. Cytologic changes in cervical smears associated with prolonged use of depot-medroxyprogesterone acetate.
    Valente PT, Schantz HD, Trabal JF.
    Cancer; 1998 Dec 25; 84(6):328-34. PubMed ID: 9915133
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.